{"transactions":[{"id":853300,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-09T21:15:52.000Z","date":"2026-03-09","kind":"sale","planned":false,"acquired":false,"shares":1287,"price":182.94,"value":235443.78,"ownership":{"direct":true},"balance_after":6512,"source":{"system":"sec-edgar","filing":"0001784606-26-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460626000012/edgardoc.xml","form_type":"4"}},{"id":853299,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-09T21:15:52.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":1436,"price":186.7723,"value":268205.0228,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $186.06 to $186.9115. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":7799,"source":{"system":"sec-edgar","filing":"0001784606-26-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460626000012/edgardoc.xml","form_type":"4"}},{"id":873791,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-02T22:14:13.000Z","date":"2026-02-27","kind":"sale","planned":false,"acquired":false,"shares":1117,"price":190.9073,"value":213243.4541,"ownership":{"direct":true},"balance_after":9235,"source":{"system":"sec-edgar","filing":"0001784606-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460626000007/edgardoc.xml","form_type":"4"}},{"id":873790,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-02T22:14:13.000Z","date":"2026-02-26","kind":"sale","planned":false,"acquired":false,"shares":1253,"price":194.1119,"value":243222.2107,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $193.7300 to $194.4100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":10352,"source":{"system":"sec-edgar","filing":"0001784606-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460626000007/edgardoc.xml","form_type":"4"}},{"id":873789,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-02T22:14:13.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":2223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2026, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":11605,"source":{"system":"sec-edgar","filing":"0001784606-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460626000007/edgardoc.xml","form_type":"4"}},{"id":934105,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-22T01:39:01.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":2370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents ordinary shares of the Issuer that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2023. The performance-based vesting requirements applicable to such awards were satisfied on January 16, 2026, which represents the date on which the level of performance\nattained was certified."}],"balance_after":9382,"source":{"system":"sec-edgar","filing":"0001784606-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460626000002/edgardoc.xml","form_type":"4"}},{"id":975785,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-12-09T22:25:20.000Z","date":"2025-12-05","kind":"exercise","planned":false,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 1, 2018, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The option fully vested as of March 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":140.67,"expiration_date":"2028-02-29","underlying":"Ordinary Shares","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001784606-25-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460625000007/edgardoc.xml","form_type":"4"}},{"id":975784,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-09T22:25:20.000Z","date":"2025-12-05","kind":"sale","planned":false,"acquired":false,"shares":4500,"price":171.2012,"value":770405.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $171.2001 to $171.2601. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":7012,"source":{"system":"sec-edgar","filing":"0001784606-25-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460625000007/edgardoc.xml","form_type":"4"}},{"id":975783,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-09T22:25:20.000Z","date":"2025-12-05","kind":"exercise","planned":false,"acquired":true,"shares":4500,"price":140.67,"value":633015.0,"ownership":{"direct":true},"balance_after":11512,"source":{"system":"sec-edgar","filing":"0001784606-25-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460625000007/edgardoc.xml","form_type":"4"}},{"id":975782,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-09T22:25:20.000Z","date":"2025-12-05","kind":"sale","planned":false,"acquired":false,"shares":160,"price":171.11,"value":27377.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person acquired 160 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 28, 2025."}],"balance_after":7012,"source":{"system":"sec-edgar","filing":"0001784606-25-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460625000007/edgardoc.xml","form_type":"4"}},{"id":992385,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-11-20T23:13:42.000Z","date":"2025-11-18","kind":"exercise","planned":false,"acquired":false,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The option was fully vested as of March 2, 2021."}],"balance_after":0,"derivative":{"exercise_price":136.18,"expiration_date":"2027-03-01","underlying":"Ordinary Shares","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0001784606-25-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460625000004/edgardoc.xml","form_type":"4"}},{"id":992384,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-11-20T23:13:42.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":5250,"price":182.07,"value":955867.5,"ownership":{"direct":true},"balance_after":7012,"source":{"system":"sec-edgar","filing":"0001784606-25-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460625000004/edgardoc.xml","form_type":"4"}},{"id":992383,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-11-20T23:13:42.000Z","date":"2025-11-18","kind":"exercise","planned":false,"acquired":true,"shares":5250,"price":136.18,"value":714945.0,"ownership":{"direct":true},"balance_after":12262,"source":{"system":"sec-edgar","filing":"0001784606-25-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460625000004/edgardoc.xml","form_type":"4"}},{"id":992382,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-11-20T23:13:42.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":69,"price":181.66,"value":12534.54,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person acquired 69 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025."}],"balance_after":7012,"source":{"system":"sec-edgar","filing":"0001784606-25-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460625000004/edgardoc.xml","form_type":"4"}},{"id":1211880,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-11T22:17:53.000Z","date":"2025-03-10","kind":"sale","planned":false,"acquired":false,"shares":1140,"price":137.81,"value":157103.4,"ownership":{"direct":true},"balance_after":7012,"source":{"system":"sec-edgar","filing":"0001765581-25-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000031/edgardoc.xml","form_type":"4"}},{"id":1211879,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-11T22:17:53.000Z","date":"2025-03-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1333,"price":138.23,"value":184260.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":8152,"source":{"system":"sec-edgar","filing":"0001765581-25-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000031/edgardoc.xml","form_type":"4"}},{"id":1235491,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-03-04T00:21:53.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":false,"shares":313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 25, 2016, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The options were fully vested as of the date of exercise."}],"balance_after":0,"derivative":{"exercise_price":123.36,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":313},"source":{"system":"sec-edgar","filing":"0001765581-25-000010","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000010/edgardoc.xml","form_type":"4"}},{"id":1235490,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-03-04T00:21:53.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The options were fully vested as of the date of exercise."}],"balance_after":0,"derivative":{"exercise_price":113.1,"expiration_date":"2030-02-26","underlying":"Ordinary Shares","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001765581-25-000010","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000010/edgardoc.xml","form_type":"4"}},{"id":1235489,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T00:21:53.000Z","date":"2025-02-28","kind":"sale","planned":false,"acquired":false,"shares":773,"price":143.295,"value":110767.035,"ownership":{"direct":true},"balance_after":9485,"source":{"system":"sec-edgar","filing":"0001765581-25-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000010/edgardoc.xml","form_type":"4"}},{"id":1235488,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T00:21:53.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":2889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":10258,"source":{"system":"sec-edgar","filing":"0001765581-25-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000010/edgardoc.xml","form_type":"4"}},{"id":1235487,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T00:21:53.000Z","date":"2025-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":497,"price":142.4308,"value":70788.1076,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":7369,"source":{"system":"sec-edgar","filing":"0001765581-25-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000010/edgardoc.xml","form_type":"4"}},{"id":1235486,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T00:21:53.000Z","date":"2025-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":371,"price":142.4271,"value":52840.4541,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":7866,"source":{"system":"sec-edgar","filing":"0001765581-25-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000010/edgardoc.xml","form_type":"4"}},{"id":1235485,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T00:21:53.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":313,"price":144.4162,"value":45202.2706,"ownership":{"direct":true},"balance_after":8237,"source":{"system":"sec-edgar","filing":"0001765581-25-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000010/edgardoc.xml","form_type":"4"}},{"id":1235484,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T00:21:53.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":true,"shares":313,"price":123.36,"value":38611.68,"ownership":{"direct":true},"balance_after":8550,"source":{"system":"sec-edgar","filing":"0001765581-25-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000010/edgardoc.xml","form_type":"4"}},{"id":1235483,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T00:21:53.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":4500,"price":144.4162,"value":649872.9,"ownership":{"direct":true},"balance_after":8237,"source":{"system":"sec-edgar","filing":"0001765581-25-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000010/edgardoc.xml","form_type":"4"}},{"id":1235482,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T00:21:53.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":true,"shares":4500,"price":113.1,"value":508950.0,"ownership":{"direct":true},"balance_after":12737,"source":{"system":"sec-edgar","filing":"0001765581-25-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000010/edgardoc.xml","form_type":"4"}},{"id":1297358,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2025-01-22T23:46:35.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":1641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2022. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2025, which represents the date on which the level of performance attained was certified."}],"balance_after":8237,"source":{"system":"sec-edgar","filing":"0001805688-25-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000180568825000007/edgardoc.xml","form_type":"4"}},{"id":1342721,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2024-12-04T22:20:59.000Z","date":"2024-12-02","kind":"sale","planned":false,"acquired":false,"shares":53,"price":122.49,"value":6491.97,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person acquired 53 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 29, 2024."}],"balance_after":6596,"source":{"system":"sec-edgar","filing":"0001765581-24-000090","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000090/edgardoc.xml","form_type":"4"}},{"id":1483211,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2024-06-12T00:15:22.000Z","date":"2024-06-07","kind":"sale","planned":false,"acquired":false,"shares":163,"price":108.825,"value":17738.475,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"163 ordinary shares were acquired on May 31, 2024 under a Section 423 Employee Stock Purchase Plan."}],"balance_after":6596,"source":{"system":"sec-edgar","filing":"0001765581-24-000044","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000044/edgardoc.xml","form_type":"4"}},{"id":1586358,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2024-03-08T23:07:30.000Z","date":"2024-03-07","kind":"sale","planned":false,"acquired":false,"shares":1768,"price":116.98,"value":206820.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $116.93 to $117.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":6596,"source":{"system":"sec-edgar","filing":"0001765581-24-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000038/edgardoc.xml","form_type":"4"}},{"id":1586357,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2024-03-08T23:07:30.000Z","date":"2024-03-06","kind":"sale","planned":false,"acquired":false,"shares":700,"price":117.51,"value":82257.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":8364,"source":{"system":"sec-edgar","filing":"0001765581-24-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000038/edgardoc.xml","form_type":"4"}},{"id":1586356,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2024-03-08T23:07:30.000Z","date":"2024-03-06","kind":"sale","planned":false,"acquired":false,"shares":1236,"price":120.85,"value":149370.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":9064,"source":{"system":"sec-edgar","filing":"0001765581-24-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000038/edgardoc.xml","form_type":"4"}},{"id":1595013,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2024-03-06T00:54:55.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":2987,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2024, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":10300,"source":{"system":"sec-edgar","filing":"0001765581-24-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000024/edgardoc.xml","form_type":"4"}},{"id":1648966,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2024-02-13T00:29:49.000Z","date":"2023-12-04","kind":"sale","planned":false,"acquired":false,"shares":50,"price":121.3947,"value":6069.735,"ownership":{"direct":true},"balance_after":5986,"source":{"system":"sec-edgar","filing":"0001784606-24-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460624000014/edgardoc.xml","form_type":"5"}},{"id":1675057,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2024-01-19T23:19:38.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":1327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 50 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 30, 2023."}],"balance_after":7363,"source":{"system":"sec-edgar","filing":"0001784606-24-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460624000002/edgardoc.xml","form_type":"4"}},{"id":1791835,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2023-08-31T22:44:16.000Z","date":"2023-08-29","kind":"sale","planned":false,"acquired":false,"shares":142,"price":143.4686,"value":20372.5412,"ownership":{"direct":true},"balance_after":5986,"source":{"system":"sec-edgar","filing":"0001765581-23-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000102/edgardoc.xml","form_type":"4"}},{"id":1807116,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2023-08-15T21:43:07.000Z","date":"2023-08-14","kind":"sale","planned":false,"acquired":false,"shares":158,"price":138.1575,"value":21828.885,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.77 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":6128,"source":{"system":"sec-edgar","filing":"0001765581-23-000074","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000074/edgardoc.xml","form_type":"4"}},{"id":1860313,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2023-06-09T20:55:37.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":126,"price":127.916,"value":16117.416,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person acquired 126 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 31, 2023."}],"balance_after":6286,"source":{"system":"sec-edgar","filing":"0001765581-23-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000050/edgardoc.xml","form_type":"4"}},{"id":1946460,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-17T22:10:39.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":1023,"price":133.22,"value":136284.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":6286,"source":{"system":"sec-edgar","filing":"0001765581-23-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000038/edgardoc.xml","form_type":"4"}},{"id":1965454,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-08T02:18:22.000Z","date":"2023-03-05","kind":"sale","acquired":false,"shares":1148,"price":140.7612,"value":161593.8576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $140.7559 to $140.7631. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":7309,"source":{"system":"sec-edgar","filing":"0001765581-23-000026","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000026/edgardoc.xml","form_type":"4"}},{"id":1965453,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-08T02:18:22.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":2523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2023, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":8457,"source":{"system":"sec-edgar","filing":"0001765581-23-000026","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000026/edgardoc.xml","form_type":"4"}},{"id":2093165,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2022-12-07T23:38:33.000Z","date":"2022-12-05","kind":"sale","acquired":false,"shares":63,"price":152.0632,"value":9579.9816,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"63 ordinary shares were acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2022."}],"balance_after":5934,"source":{"system":"sec-edgar","filing":"0001765581-22-000134","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000134/edgardoc.xml","form_type":"4"}},{"id":2181282,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-08-17T20:41:39.000Z","date":"2022-08-15","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":4500,"derivative":{"exercise_price":113.1,"expiration_date":"2030-02-26","underlying":"Ordinary Shares","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001765581-22-000104","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000104/edgardoc.xml","form_type":"4"}},{"id":2181281,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2022-08-17T20:41:39.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":2000,"price":160.29,"value":320580.0,"ownership":{"direct":true},"balance_after":5934,"source":{"system":"sec-edgar","filing":"0001765581-22-000104","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000104/edgardoc.xml","form_type":"4"}},{"id":2181280,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2022-08-17T20:41:39.000Z","date":"2022-08-15","kind":"exercise","acquired":true,"shares":2000,"price":113.1,"value":226200.0,"ownership":{"direct":true},"balance_after":7934,"source":{"system":"sec-edgar","filing":"0001765581-22-000104","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000104/edgardoc.xml","form_type":"4"}},{"id":2181279,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2022-08-17T20:41:39.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":142,"price":156.86,"value":22274.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":5934,"source":{"system":"sec-edgar","filing":"0001765581-22-000104","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000104/edgardoc.xml","form_type":"4"}},{"id":2190623,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2022-08-09T21:17:59.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":158,"price":152.3255,"value":24067.429,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":6076,"source":{"system":"sec-edgar","filing":"0001765581-22-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000079/edgardoc.xml","form_type":"4"}},{"id":2244179,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2022-06-03T19:07:10.000Z","date":"2022-06-02","kind":"sale","acquired":false,"shares":131,"price":150.26,"value":19684.06,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Unchanged; the 131 ordinary shares sold were acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2022."}],"balance_after":6234,"source":{"system":"sec-edgar","filing":"0001765581-22-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000055/edgardoc.xml","form_type":"4"}},{"id":2274617,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2022-05-11T21:29:53.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":722,"price":147.5139,"value":106505.0358,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.51 to $147.65. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":6234,"source":{"system":"sec-edgar","filing":"0001765581-22-000047","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000047/edgardoc.xml","form_type":"4"}},{"id":2274616,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2022-05-11T21:29:53.000Z","date":"2022-05-10","kind":"sale","acquired":false,"shares":273,"price":144.1792,"value":39360.9216,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.11 to $144.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":6956,"source":{"system":"sec-edgar","filing":"0001765581-22-000047","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000047/edgardoc.xml","form_type":"4"}},{"id":2274615,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2022-05-11T21:29:53.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":11,"price":150.49,"value":1655.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":7229,"source":{"system":"sec-edgar","filing":"0001765581-22-000047","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000047/edgardoc.xml","form_type":"4"}},{"id":2274614,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2022-05-11T21:29:53.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":1056,"price":148.9281,"value":157268.0736,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.92 to $149.91 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":7240,"source":{"system":"sec-edgar","filing":"0001765581-22-000047","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000047/edgardoc.xml","form_type":"4"}},{"id":2341459,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-09T22:51:14.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":2488,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2022, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":8296,"source":{"system":"sec-edgar","filing":"0001765581-22-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000013/edgardoc.xml","form_type":"4"}},{"id":2434731,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2022-01-14T22:19:47.000Z","date":"2021-11-30","kind":"other","acquired":true,"shares":63,"price":101.4645,"value":6392.2635,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2021. This transaction is exempt pursuant to Rule 16b-3(c)."}],"balance_after":5808,"source":{"system":"sec-edgar","filing":"0001765581-22-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000007/edgardoc.xml","form_type":"5"}},{"id":2434730,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2022-01-14T22:19:47.000Z","date":"2021-09-03","kind":"sale","acquired":false,"shares":143,"price":136.48,"value":19516.64,"ownership":{"direct":true},"balance_after":5745,"source":{"system":"sec-edgar","filing":"0001765581-22-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000007/edgardoc.xml","form_type":"5"}},{"id":2434729,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2022-01-14T22:19:47.000Z","date":"2021-09-03","kind":"sale","acquired":false,"shares":147,"price":136.62,"value":20083.14,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 147 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 28, 2021. This acquisition is exempt pursuant to Rule 16b-3(c)."}],"balance_after":5888,"source":{"system":"sec-edgar","filing":"0001765581-22-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000007/edgardoc.xml","form_type":"5"}},{"id":2608304,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2021-08-10T21:31:13.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":157,"price":147.96,"value":23229.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":6035,"source":{"system":"sec-edgar","filing":"0001765581-21-000100","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000100/edgardoc.xml","form_type":"4"}},{"id":2796653,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2021-03-10T21:25:52.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":961,"price":161.5,"value":155201.5,"ownership":{"direct":true},"balance_after":6045,"source":{"system":"sec-edgar","filing":"0001765581-21-000044","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000044/edgardoc.xml","form_type":"4"}},{"id":2796652,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2021-03-10T21:25:52.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":1089,"price":161.6052,"value":175988.0628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $161.6026 to $161.6082. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":7006,"source":{"system":"sec-edgar","filing":"0001765581-21-000044","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000044/edgardoc.xml","form_type":"4"}},{"id":2825850,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2021-03-01T22:47:03.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":1895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2021, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":8095,"source":{"system":"sec-edgar","filing":"0001765581-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000014/edgardoc.xml","form_type":"4"}},{"id":2953191,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2020-12-08T22:09:13.000Z","date":"2020-12-04","kind":"sale","acquired":false,"shares":62,"price":152.5479,"value":9457.9698,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 62 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2020."}],"balance_after":6200,"source":{"system":"sec-edgar","filing":"0001765581-20-000129","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000129/edgardoc.xml","form_type":"4"}},{"id":3057092,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2020-08-14T21:33:49.000Z","date":"2020-08-12","kind":"sale","acquired":false,"shares":142,"price":123.8,"value":17579.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":6200,"source":{"system":"sec-edgar","filing":"0001765581-20-000091","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000091/edgardoc.xml","form_type":"4"}},{"id":3061672,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2020-08-11T23:51:22.000Z","date":"2020-08-07","kind":"sale","acquired":false,"shares":158,"price":125.8702,"value":19887.4916,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":6342,"source":{"system":"sec-edgar","filing":"0001765581-20-000089","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000089/edgardoc.xml","form_type":"4"}},{"id":3120106,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2020-06-05T20:47:33.000Z","date":"2020-06-05","kind":"sale","acquired":false,"shares":138,"price":124,"value":17112.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 138 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 29, 2020."}],"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001765581-20-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000059/edgardoc.xml","form_type":"4"}},{"id":3210697,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2020-03-13T22:48:45.000Z","date":"2020-03-12","kind":"sale","acquired":false,"shares":600,"price":102.17,"value":61302.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001765581-20-000047","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000047/edgardoc.xml","form_type":"4"}},{"id":3217485,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2020-03-10T22:05:14.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":568,"price":111.4481,"value":63302.5208,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $111.4401 to $111.4550. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected."}],"balance_after":7100,"source":{"system":"sec-edgar","filing":"0001765581-20-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000042/edgardoc.xml","form_type":"4"}},{"id":3217484,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2020-03-10T22:05:14.000Z","date":"2020-03-06","kind":"sale","acquired":false,"shares":232,"price":119.1732,"value":27648.1824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":7668,"source":{"system":"sec-edgar","filing":"0001765581-20-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000042/edgardoc.xml","form_type":"4"}},{"id":3224326,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2020-03-06T00:42:12.000Z","date":"2020-03-04","kind":"sale","acquired":false,"shares":253,"price":118.67,"value":30023.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":7900,"source":{"system":"sec-edgar","filing":"0001765581-20-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000028/edgardoc.xml","form_type":"4"}},{"id":3224325,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2020-03-06T00:42:12.000Z","date":"2020-03-03","kind":"sale","acquired":false,"shares":247,"price":119.7499,"value":29578.2253,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":8153,"source":{"system":"sec-edgar","filing":"0001765581-20-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000028/edgardoc.xml","form_type":"4"}},{"id":3237748,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-03-02T23:28:44.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":6500,"derivative":{"exercise_price":113.1,"expiration_date":"2030-02-26","underlying":"Ordinary Shares","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001765581-20-000016","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000016/edgardoc.xml","form_type":"4"}},{"id":3237747,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2020-03-02T23:28:44.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2020, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":8400,"source":{"system":"sec-edgar","filing":"0001765581-20-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000016/edgardoc.xml","form_type":"4"}},{"id":3348150,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-12-09T22:19:51.000Z","date":"2019-12-05","kind":"exercise","acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 25, 2016, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":313,"derivative":{"exercise_price":123.36,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001765581-19-000100","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000100/edgardoc.xml","form_type":"4"}},{"id":3348149,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2019-12-09T22:19:51.000Z","date":"2019-12-05","kind":"sale","acquired":false,"shares":82,"price":149.84,"value":12286.88,"ownership":{"direct":true},"balance_after":5800,"source":{"system":"sec-edgar","filing":"0001765581-19-000100","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000100/edgardoc.xml","form_type":"4"}},{"id":3348148,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2019-12-09T22:19:51.000Z","date":"2019-12-05","kind":"sale","acquired":false,"shares":1667,"price":148.889,"value":248197.963,"ownership":{"direct":true},"balance_after":5882,"source":{"system":"sec-edgar","filing":"0001765581-19-000100","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000100/edgardoc.xml","form_type":"4"}},{"id":3348147,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & PAO"}}],"security":"Ordinary Shares","published_at":"2019-12-09T22:19:51.000Z","date":"2019-12-05","kind":"exercise","acquired":true,"shares":1667,"price":123.36,"value":205641.12,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 82 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 29, 2019."}],"balance_after":7549,"source":{"system":"sec-edgar","filing":"0001765581-19-000100","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000100/edgardoc.xml","form_type":"4"}},{"id":3440881,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance& PAO"}}],"security":"Ordinary Shares","published_at":"2019-08-12T21:54:43.000Z","date":"2019-08-08","kind":"grant","acquired":true,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of August 5, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":5800,"source":{"system":"sec-edgar","filing":"0001765581-19-000084","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000084/edgardoc.xml","form_type":"4"}}]}